Study could lead to vaccines and treatment for dengue virus

July 2, 2015, Vanderbilt University Medical Center
Artistic rendering of the antibody 2D22 neutralizing the dengue virus serotype 2 (DENV-2). Credit: Guntur Fibriansah / Duke-NUS Graduate Medical School Singapore

Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.

The finding, reported today July 2 in the journal Science, could lead to the first effective therapies and vaccines against , a complex of four distinct but related mosquito-borne viruses that infect about 390 million people a year and which are a leading cause of illness and death in the tropics.

"Scientists in the antibody discovery group of the Vanderbilt Vaccine Center continue to make great strides in developing novel antiviral drugs, such as this human antibody that not only kills but also prevents enhanced dengue disease," said co-corresponding author and center director James Crowe Jr., M.D., Ann Scott Carell Professor.

The four "serotypes" of dengue are distinguished by different antigens, or proteins on the viral envelope that elicit immune responses. What makes dengue so challenging, and so dangerous, is that generated against one serotype do not protect against the others.

In fact, they actually can enhance infection by a second serotype, a process known as antibody-dependent enhancement (ADE) of infection. Sequential infections increase the risk for and , characterized by fever, vomiting, internal bleeding and potentially fatal circulatory collapse.

The researchers previously generated in the lab against a complex epitope, or antigenic portion of the viral envelope. In the current study, they used cryo-electron microscopy to freeze samples at very low temperatures so they could visualize antibody-antigen binding almost down to the atomic level.

In this way they were able to identify a human monoclonal antibody against dengue virus type 2 (DENV2) that "locked" across an array of envelope proteins. In a mouse model, this prevented the virus from fusing to its target cell, thus it prevents infection.

The antibody also was remarkable in that it has a second major function - it blocks the binding of the other class of antibodies that otherwise would enhance infection.

This specific "epitope," or portion of the envelope proteins elicits a specific immune response, thus it is a potential target for the development of dengue vaccines and therapeutics, the researchers concluded.

Explore further: Team finds powerful dengue neutralizing antibody

More information: Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers, www.sciencemag.org/lookup/doi/ … 1126/science.aaa8651

Related Stories

Team finds powerful dengue neutralizing antibody

February 20, 2015
A new Duke-NUS-led study has identified a super-potent antibody which requires a minute amount to neutralize the dengue virus.

Antibodies discovery could lead to universal dengue vaccine 

December 16, 2014
A major new class of antibodies that can make the four different types of dengue virus (DENV) non-infectious has been discovered by a group of international researchers, including from the University of Melbourne.

Scientists identify the skin immune cells targeted by the dengue virus

June 24, 2015
Cells in the skin immune system that act as 'gateways' enabling the dengue virus to spread through the body have been identified by A*STAR researchers.

Human antibody for dengue virus isolated

June 22, 2012
(Phys.org) -- A group of scientists in Singapore and the UK have isolated a human antibody capable of effectively neutralizing the mosquito-borne dengue virus. Dengue fever is currently incurable and infects an estimated ...

Targeting key cells for a dengue virus infection model

November 5, 2014
Dengue virus infects hundreds of millions of people living in tropical countries every year. Transmitted via mosquito bites, the virus typically causes fever, but may also lead to potentially fatal organ failure. The development ...

Research advances therapy to protect against dengue virus

April 8, 2013
Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step closer, thanks ...

Recommended for you

'Game changer' tuberculosis drug cures 9 in 10

October 22, 2018
A new treatment for a drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a trial hailed Monday as a "game changer" in the fight against the global killer.

AI doctor could boost chance of survival for sepsis patients

October 22, 2018
Scientists have created an artificial intelligence system that could help treat patients with sepsis.

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

Scientists in Sweden may have figured out one way acne bacteria defies treatment

October 22, 2018
Researchers in Sweden have discovered how acne-causing bacteria feed off their human hosts. The study, which was performed at KTH Royal Institute of Technology, could make it possible to find effective ways to treat severe ...

A guide to Acute flaccid myelitis (AFM), the rare, polio-like illness making young children sick

October 22, 2018
A fast-acting, polio-like illness has sickened 62 young children, with an average age of 4, in 22 U.S. states so far this fall.

Home-based biofeedback therapy is effective option for tough-to-treat constipation

October 22, 2018
Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.